Gain Therapeutics names Jeanette Weidner vice president of finance
GANX•Gain Therapeutics appointed Jeanette Weidner vice president of finance on October 22, effective October 28, 2026. She will also serve as principal financial officer and principal accounting officer.
1. Finance leadership appointment
Weidner most recently served as a financial consultant at Senseonics Holdings from March 2025 to October 2026, focusing on financial reporting and operational accounting. Previously, she was vice president of finance at OncoC4 from March 2021 to January 2025.
